NFKB1 and diabetes mellitus: In this report, we show that irrespective of the mouse genetic background, inhibiting the NF-κB pathway during the embryonic or the neonatal stage, but not during the post-weaning period, had a significant impact on BCM and β-cell turnover and on the development of diabetes on NOD background.